click below
click below
Normal Size Small Size show me how
ID2 C/P
Infectious Diseases II - Clinical pearl
| Question | Answer |
|---|---|
| Initiate Bactrim DS or SS daily if CD4 < 200 cells/mm3 and UNdetectable viral load | - PPx for Pneumocystis jirovecii pneumonia (PJP or PCP) - FALSE - CD4 < 200 AND a detectable viral load - OR CD4 < 100 regardless of viral load |
| If sulfa allergy, CD4 < 100 what test should be done prior initiating dapsone | - PPx for Pneumocystis jirovecii pneumonia (PJP or PCP) - dapsone can cause hemolysis if G6PD deficiency - Alternative • atovaquone - D/c PPx if CD4 ≥ 200 for ≥ 3 months AND remains on ART |
| IgG positive AND CD4 < 100 cells/mm | - A positive IgG indicates prior exposure (focal neurologic deficits) - SMX/TMP DS daily |
| Initiate Bactrim SS daily if IgG positive AND CD4 < 100 cells/mm3 | - FALSE - Bactrim DS daily - Covers: PCP and toxoplasmosis - Alternatives: atovaquone - Or dapsone + pyrimethamine + leucovorin - D/c PPx if CD4 ≥ 200 for ≥ 3 months AND remains on ART |
| Not taking ART, CD4 count < 50 cells/mm | - Ppx for Mycobacterium avium complex (MAC) - Azithromycin 1,200 mg QW - Azithromycin 600 mg Q2W (if nause w 1,200mg) - |
| If CD4 count < 50 cells/mm, Ppx for Mycobacterium avium complex (MAC) | - FALSE - Ppx if Not taking ART AND CD4 count < 50 |
| What PPx if CD4 drop below 200 cells/mm3, 100, 50 (plus other conditions) | - PCP prophylaxis (< 200 AND detectable virus load OR < 100) - Toxoplasma gondii prophylaxis (< 100 AND IgG positive) - MAC prophylaxis (< 50 AND not on ART) |
| Primary prophylaxis in transplant recipients | - Vaccinate prior to immunosuppressive therapy - High risk for CMV: letermovir or valganciclovir |
| Cytomegalovirus | CMV |
| Transplant recipients | - PPx CMV - Letermovir: kidney or bone marrow transplant - Valganciclovir in other solid organ transplants |
| PPx for CMV IF CD4 < 50 and NOT on ART | - FALSE - PPx for MAC w azithromycine 1,200mg QW - PPx for CMV in transplant recipients |
| Opportunistic infections: primary vs secondary prevention | |
| Opportunistic infections treatment | - PCP - Toxoplasma gondii encephalitis - MAC - CMV - Candidiasis "thrush" |
| Candidiasis "thrush" | - Oropharyngeal/esophageal - White film in mouth/throat - Prefer Fluconazole (HIV) ALTERNATIVE - Oropharyngeal: itraconazole, posaconazole, topicals (eg, clotrimazole troche, nystatin) - Esophageal: voriconazole, or echinocandin (eg, caspofungin) |
| Candidiasis "thrush" secondary PPx | - NOT recommend |
| Cryptococcal meningitis | - Headache, fever, blurred vision INDUCTION - Amphotericin B (liposomal) + flucytosine - Fluconazole + flucytosine - Fluconazole + Amphotericin B CONSOLIDATION - High-dose fluconazole MAINTENANCE - Low dose fluconazole (Secondary Prophylaxis) |
| Cytomegalovirus (CMV) | - Herpesvirus - Retinitis (most severe), GI tract, lungs, CNS - Valganciclovir (Produg PO for out pt), Ganciclovir (IV in pt): bone marrow suppression - Foscarnet, cidofovirIf (toxicity, resistant): nephrotoxicity - NON 2nd PPx |
| CMV Retinitis | Blurry vision, floaters, or even vision loss |
| Mycobacterium avium complex (MAC) | - Nontuberculous mycobacteria - Disseminated infection - Fever, night sweats, weight loss, anemia - Clari / azithromycin + ethambutol - Server /high virus: Add 3rd or 4th drug: Rifabutin, amikacin, streptomycin, moxifloxacin, levofloxacin |
| 2nd PPx MAC | - Same as treatment |
| 2nd PPx CMV | NON |
| Pneumocystis jirovecii pneumonia (PCP) | - Fungal infection - Subacute pneumonia - Progressive shortness of breath, dry cough, fever - Bactrim (15-20mg/d in multi doses) +/- prednisone /methylprednisolone 21Ds - Alternative: Pentamidine IV |
| 2nd PPx PCP | - SAME as primary PPx - Bactrim DS / SS QD - Alternative • atovaquone |
| Toxoplasma gondii encephalitis | - Protozoan parasite - Encephalitis - Risks: exposure to undercooked/raw meat, cat feces/litter - Pyrimethamine + leucovorin + sulfadiazine OR bactrim - Pyrimethamine + leucovorin + Clindamycin |
| Role of leucovorin in regimen for Toxoplasma gondii encephalitis | - Decrese bone marrow toxicity associated with pyrimethamine |
| 2nd PPx Toxoplasma gondii encephalitis | Same as treatment (reduced dose) |
| Toxoplasma gondii encephalitis: regimen for primary and secondary are the same | - Same if Bactrim Alternative - 1st PPx: atovaquone OR dapsone + pyrimethamine + leucovorin - 2nd PPx: Pyrimethamine + leucovorin + sulfadiazine OR Pyrimethamine + leucovorin + Clindamycin |
| 2nd OIs PPx for | - PCP - Toxoplasma gondii encephalitis - MAC |
| Meningitis causes | - Virus (most common) - Bacteria - Fungi |
| Meningitis common bacteria: - Group B Streptococcus - Streptococcus pneumoniae - Neisseria meningitidis | GRAM (+) - Group B streptococcus (cocci chain); Streptococcus pneumoniae (diplococci) - Listeria monocytogenes (rods) GRAM (-) - Neisseria meningitidis (diplococci): - Haemophilus influenzae (Coccobacilli) - E. coli (rods) |
| Meningitis clinical presentation | - Severe headache - HIGH Fever - Confusion - Stiff neck (pain with flexion: đau khi cúi cổ) / Nuchal rigidity - Other: • Chills • Vomiting • Seizures • Characteristic rash • Photophobia |
| Meningitis: Dx | - Lumbar Puncture (cerebral spinal fluid, CSF) prior initiate ABx - Culture - CSF analysis (LOW Glucose content, HIGH protein & WBC) - PCR (quicker) |
| Meningitis treatment: when to initiate IV dexamethasone | - Just before or with first-dose ABx - Cnt 4 days - D/C If S. pneumoniae |
| Agents do NOT penetrate into the CSE | - Zosyn - Clindamycin - Cefazolin |
| Meningitis treatment for neonant: can replace Zosyn to other ceftriaxone | - NO - Zosyn does NOT penetrate into CSF |
| Suspected bacteria in neonate with meningitis | - E. coli - Group B streptococci (strep agalactiae) - Listeria spp. - ABx: Ampicillin + Cefotaxime or gentamicin |
| Suspected bacteria in 1-23 months with meningitis | - S. pneumoniae - N. meningitidis - H. influenzae - E. coli - Group B streptococci |
| Suspected bacteria in 2-50 years with meningitis | - S. pneumoniae - N. meningitidis |
| Empiric Abx for 1m - 50 yrs w meningitis | - Ceftriaxone or cefotaxime - Vancomycin (double coverage for Streptococci) |
| Meningitis - Duration of therapy | • 7 days: HN • 10-14 days: S. pneumoniae • 14-21 days: Group B streptococcus (S. agalactiae) • ≥ 21 days: Listeria, gram-negative rods |
| cefazolin (t½ = 2 hours), redose every 4 hours | |
| Cardiac, Orthopedic, and Vascular Surgeries: Concerning organisms | - Skin flora: staphylococci & streptococci - Preferred ABx: Cefazolin or cefuroxime - Beta-lactam allergy: Vancomycin or clindamycin - Suspected MRSA as well: Cefazolin + Vanco |
| Gastrointestinal Surgeries: Concerning organisms | - Skin flora, AND - GI flora: E.coli, Klebsiella, Bacteroides fragilis (anaerobes) |
| Gastrointestinal Surgeries: selecting ABx | - Unasyn or - Cefoxitin or cefotetan or - Cefazolin + metronidazole Beta-lactam allergy - Metronidazole or clindamycin, PLUS - Fluoroquinolone or aminoglycoside |
| Otalgia (ear pain): tugging or rubbing the ears Irritability: crying, "fussiness" | |
| Initial Management Otitis Media if < 6 mos | - ABx |
| Initial Management SERVER Otitis Media: - Lotalgia-Đau tai- lasting 48 hours - Fluid draining from the ear - Tem: 102.2oF or 39oC | - ABx |
| Initial Management w both ears and 6-23 mo | - ABx |
| Initial Management if - 6-23 months w one ear - > = 2yrs 1 or 2 ears | ABx or Observation (2-3 days) |
| Otitis Media causative | - Virus - Bacteria: S. pneumoniae, H. influenzae, and Moraxella. catarrhalis |
| Otitis Media ABx selection | - ABx: : amoxicillin or augmentin : 90 mg/kg/day (High dose to penetrate) - Mild pen allergy: 2nd or 3th cepha - True allergy: Azithromycin - Treatment failure w amoxicillin: Augmentin - Treatment failure w Augmentin: Ceftriaxone IM x 3 days |
| Otitis Media: when Augmentin is indicated instead of amoxicillin | - Taken Amoxicillin within 30 Ds |
| Otitis Media: duration of treatment | 5-10 days |
| Types of Upper Respiratory Tract Infections | - Common cold - Influenza - Pharyngitis - Acute sinusitis - Acute Otitis Media |
| Common cold | - Rhinovirus, seasonal coronavirus - Sneezing, runny nose, congestion, mild sore throat and/or cough - Less than 101ºF, no myalgias - OTC |
| Influenza | - Influenza virus - Acute/sudden onset, fever, chills, fatigue, myalgias, dry cough, sore throat, headache - More severe than common cold - Antivirus |
| Influenza | - Oseltamivir (Tamiflu) - Baloxavir marboxil (Xofluza) - Out pt: Onset is ≤ 48 hours - Server (hospitalize, CHF, Lung, Liver, renal) : START |
| Neuraminidase inhibitors | - Oseltamivir (Tamiflu) |
| Endonuclease inhibitor (inhibit influenza viral replication) | - Baloxavir marboxil (Xofluza) - Single ONE-time dose |
| Pharyngitis | - Respiratory viruses - Group A Streptococcus (S. pyogenes) - Rapid antigen test: tonsil swab; Culture - Severe sore throat, fever, swollen lymph nodes, white patches (exudates) on the tonsils - Absence of cough, runny nose, congestion |
| Pharyngitis - ABx option | - Penicillin VK - Amoxicillin - Alternatives: 1st / 2nd cepha, macrolide, clindamycin |
| Acute sinusitis causations | - Respiratory viruses - S. pneumoniae, H. influenzae, M. catarrhalis |
| Acute sinusitis symtoms | - Nasal congestion, purulent nasal drainage, facial/ear/dental pain or pressure, headache, fever - Absence of cough |
| Acute sinusitis - Anti-infective therapy criteria | - Symptoms ≥ 10 days or - Symptoms worsen after initial improvement |
| Acute sinusitisTreatment options | - Symptom-specific OTC products - Watchful waiting - Amoxicillin +/- clavulanate if s/x not improved w/t 7 Ds. Doxycilline (allergy), NOOO azithromycin (strep pneu) |
| Acute Bronchitis pathogens | VIRUSES • Rhinovirus • Influenza • Seasonal coronavirus BACTERIA: rare • S. pneumoniae • H. influenzae • Atypicals • Bordetella pertussis |
| Acute Bronchitis s/x | • Cough for 1-3 weeks • +/- sputum production • LACK systemic symptoms (eg, fever, chills, malaise) • Wheezing or rhonchi audible on auscultation • NORMAL chest x-ray NO ABx |
| Pertussis (Whooping Cough) | - Bordetella pertussis - Droplet - highly contagious - Azithromycin, clarithromycin |
| COPD exacerbation | - H. influenzae, M. catarrhalis, S. pneumoniae - Pollution - Unknown |
| Management of acute COPD exacerbation | Supportive treatment: • Oxygen • Short-acting inhaled bronchodilators • IV or PO steroids |